| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1,350.2 | 1,273.7 |
| Gross profit | 1,044.1 | 989.5 |
| Profit before tax | 106.6 | 74.8 |
| Net income | 58.8 | 43.2 |
| EPS (diluted, $ a share) | $0.55 | $0.42 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +36.1% |
|---|---|
| Revenue, year on year | +6.0% |
| Gross margin | 77.3% |
| Operating margin | 10.3% |
10-Q filed with the SEC, NYSE: HLF. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Herbalife Ltd.: key numbers
- Share price
- $16.15Close, Nov 16
- Market cap
- $1.69B
- Shares outstanding
- 104.9MLatest SEC cover page
- Sector
- Trade & Services
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' SundriesSIC 5122
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Herbalife Ltd.
All →Herbalife Earnings Call: Key Takeaways
Herbalife delivered a strong Q3 2026 beat, driven by 39% growth in India and 8.6% global volume increases, while transitioning to a modular technology platform and expanding the Bionic brand.
- Call
- Nov 2, 2026, 5:00 PM ET
Herbalife Financial Results
Herbalife reported third quarter 2026 net sales of $1.35 billion, representing 6.0% year-over-year growth and its fifth consecutive quarter of expansion. The company also announced a new $250 million share repurchase program and the appointment of Scott Schaefer as CFO.
- Term
- Q3 2026